Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Pallavi Bedi (Edinburgh, United Kingdom), Pallavi Bedi, James Chalmers, Adriano Rossi, Adam Hill. Atorvastatin as an anti inflammatory in bronchiectasis. Eur Respir J 2015; 46: Suppl. 59, 360

Member's Comments

No comment yet.

Related content which might interest you: Anti-inflammatory therapy for sarcoidosis patients Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Atorvastatin as novel treatment in bronchiectasis patients colonized with pseudomonas aeruginosa Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Exacerbations in non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Pirfenidone therapy for patients with progressive idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 3 Year: 2014 Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Anti-inflammatory therapies in bronchiectasis Source: Eur Respir Mon 2011; 52: 223-238 Year: 2011 Exacerbations of bronchiectasis: Etiology and outcome Source: International Congress 2016 – Orphan diseases II Year: 2016 Atorvastatin lowers inflammatory sputum mediators in smokers with asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Predictors of exacerbations in patients with bronchiectasis Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Eosinophilic inflammation amplifies the prednisolone-induced prothrombotic state in asthma Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Effect of long term azithromycin on exacerbations in non CF bronchiectasis Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Implication of IL-18 in the chronic inflammation of severe refractory asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014